BUDGET IMPACT ANALYSIS OF THE INCLUSION OF TOFACITINIB AS AN ALTERNATIVE FOR RHEUMATOID ARTHRITIS TREATMENT AFTER CONVENTIONAL DMARDS FAILURE IN CHILE
Abstract
Authors
M.V. Gutierrez-Ardila
M.V. Gutierrez-Ardila
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now